Heart Congress 2019 | Dubai | UAE | Allied Conferences | Call for Abstracts

Cardiology is a branch of medicine dealing with disorders of the heart be it human or animal. The field incorporates medical analysis and treatment of innate heart defects, coronary vein malady, heart disappointment, valvular coronary illness andelectrophysiology. Doctors who represent considerable authority in this field of prescription are called cardiologists. Pediatric cardiologists are pediatricians who are specialized in cardiology.

Related Conferences: 4th AnnualAdvances pulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference, November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Cardiac disease is the disorder that influences your heart. Diseases under the coronary disease incorporate blood vessel diseases, for example, coronary artery disease; arrhythmias; and heart imperfections you're brought into the world with for example congenital heart defects, Hypertension, heart failure, Cardiomyopathy, Ischemic heart disease, etc. CardiacDisease is a general term for conditions influencing the heart or veins. It's normally connected with the development of fat deposits inside the arteries– known as atherosclerosis – and an expanded danger of blood clots.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Heartfailure burden is on the constant increase in our country and overthe last few years this is being increasingly recognized as a subspecialty. Heart Congressapproaches for better medical management and interventions have proved toimprove the quality of life of these patients. Heart failure happenswhen the pumping activity of your heart isn't sufficiently able to move bloodaround, particularly under pressure. Moreover, the heart muscle may not unwindappropriately to oblige the progression of blood once again from the lungs tothe heart. These variations from the norm in cardiac function can make fluid toback up in your lungs and in different pieces of your body. At times the fluidin your lungs can accumulate to the point where it can cause a dangerouscondition called acute pulmonaryedema, requiring crisis treatment.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Atrialfibrillation (AF), the most common sustained cardiacarrhythmia, is associated with increased rates of mortality. Inflammation has longbeen known to play a role in the pathogenesis of atrial fibrillation. Therapiesincluding anticoagulants, anti-arrhythmic medications, devices, andnon-pharmacologic procedures in the last 30 years have improved patients'functionality with the disease. It stays basic that further examination into atrial fibrillation thestudy of disease transmission, hereditary qualities, detection, and medicineskeeps on pushing forward quickly.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

PaediatricCardiology is basically focused on clinical examinations, experimentalundertakings and assessment of new procedures with potential applications to paediatricresearch on people. The objective of this session is to quickeninterchanges in paediatriccardiology, to encourage the knowledge sharing and to invigorate theresearch in the field. Clinical papers emphasizing medical and surgical aspectsof all aspects of heart disease ininfants, children, and adolescents, including embryology and anatomy,physiology and pharmacology, biochemistry, pathology, genetics, radiology,clinical aspects, investigative cardiology, electrophysiology and echocardiography, and cardiacsurgery are welcomed.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

The improvement of heartsurgery and cardiopulmonary sidestep procedures has lessened thedeath rates of these surgeries to generally low positions. For example, repairsof inborn heartdeformities are at present assessed to have 4-6% death rates.It is often used to treat complications of ischemicheart diseases like coronary artery bypass grafting, to correct congenitalheart disease; or to treat valvular heart disease from variouscauses, including endocarditis,rheumatic heart disease, and atherosclerosis. There will be expandeddiscussions regarding the new advanced technologies in cardiac surgery and transplantationprocesses. This session focuses to provide a platform for researchers,practitioners and educators to present and discuss the most recent innovations,trends, and concerns as well as practical challenges encountered, and solutionsadopted in the fields of Cardiology and Cardiac Surgery.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Diabetes patients have anincreased risk of heartdisease. Moreover, cardiovascular complications are the leadingcauses of morbidity and mortality among patients with diabetes.Diabetes could legitimately influence themyocardial function and viability, even without atheroscleroticocclusive illness, henceforth leading to heart attack and diabetic cardiomyopathy. Currenttreatment of basic heart issues that are quickened by diabetes isn'tdistinctive to that of nondiabetic patients with cardiovascular pathologies. HeartCongress 2019 invite papers related to diabetes and cardiologywhich highlights all aspects of both diseases’ interaction:epidemiology, genetics, physiopathology, treatment, andprevention.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World HeartRhythm Conference, November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Thyroid gland issues can resultin the cardiac problems. One of the most important reasons to diagnose andtreat thyroid disease is to prevent the cardiac conditions that can result fromit. Thyroiddisease affects the heart either by producing too little thyroidhormone (a condition called hypothyroidism) or toomuch thyroid hormone (called hyperthyroidism). Bothtype of thyroid disorders can have a significant effect on the heart.Researchers shows two thyroid disorders – subclinical hypothyroidism and low T3syndrome – might make heartfailure worse.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Cardiovascularimaging is a basic advance in the exact determination of numerousheart conditions. Through these techniques, cardiologist canassess the size and structure of a patient's heart and perceive how well itfunctions. This session will pave way to develop ultrasound contrast agents andimaging systems with the goal of moving basic discoveries in ultrasound-based molecularimaging into clinical practice.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Cardiac nurses andallied experts are on the bleeding edge of the fight to decrease the weight of cardiovasculardisease and will examine better approaches to assess risk, prompt andtreat their patients.Cardiovascular nurses have been a significant supporter of improving cardiachealth since the commencement of the coronary care units. Cardiovascularnursing has advanced monstrously alongside improvements in innovationand the treatment and prevention of cardiac disease. Heartresearch and innovative work prompts fast clinical changes which require nursesand allied experts to be refreshed with the most recent information ontreatment and care. Future research on should be led on the role of cardiovascularnurse in patient instruction and risk factor management in theanticipation of CVD, just as in intense heart care. In this session, heartcongress 2019 invites the researchers to submit their works onthe topics but are not limited to Acute and Chronic HeartFailure; Improving Care in Hospital and Community; Coping withPatient and Family Issues at End of Life; Prevention and Support in Transplant,among others.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Cardiologydisease is the main killer of women in America. Every year a largernumber of women die of cardiologydisease than men, yet cardiology disease and related risk componentsare frequently missed in ladies. Indications of coronaryheart disease and heart failure, for instance, are frequentlydiffer in women than their male partners. Women are likewise less inclined toget ideal treatment for certain heart conditions. A women’s side effects arefrequently not quite the same as a man's, and she's substantially more likelythan a man to die within a time of showing at least a bit of heart attack.Research is just currently starting to reveal the biological, medicinal, andsocial bases of these and different contrasts. The expectation is that newlearning will prompt advances in fitting anticipation and treatment to ladies.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Digitalhealth is the use of digital information, data and communicationtechnologies to collect, share and analyse health information to improvepatient health and health care delivery. In spite of the fact that cardiology is onthe front line of therapeutic and methodology related advancements, the fieldis lacking in selection of digital tools in medicinal services delivery. Theseadvances could encourage and propel progressively regular randomized clinicaltrials (RCTs), which is especially essential since RCTs are ending upprogressively costly and complex, are moderate to finish and takes time toimplement into practice. Mobilehealth or mHealth, is the subset of digital health thatfocuses on the use of mobile and wearable devices and software applicationsThis session is tailored to give a platform to focus on current and potentialapplications of artificial intelligence in cardiovascularmedicine. This session at HeartCongress 2019 expects the researchers to submit their researchabstracts on topics but are not limited to AI inCardiology, early applications of AI in general and specific to healthcare,and a pioneering application of AI inCardiology, AI in medical informatics, imaging processing, and clinicaldecision making. This session is intended for cardiologists, critical carephysicians, clinical investigators, computer scientists, data scientists,engineers, and other medical and computer professionals who are interested in acontemporary review of machine learning and its applications to medicine andspecifically to cardiology.

Related Conferences: 4th AnnualAdvances inPulmonary Hypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

CardiovascularPharmacology deals with the study of drug action which exertsa biochemical or physiological effect on the tissue, cell, organ or organism.The interactions affect normal or abnormal biochemical function. Thecardiovascular group is studying the connections between salt intake or obesityon blood pressure control mechanisms. These investigators use state of the artmolecular, cellular and integrative approaches to study the vascular functionand neural control of blood pressure. It elaborates safety data of detrimentaleffects of new cardiovascularmedicines. Pharmacology ofvascular endothelium deals with modifications of endothelial cells and thevasculature play a crucial part in the pathogenesis of a wide range of the mostdreadful of human diseases, as endothelial cells have the vital role ofparticipating in the maintenance of patent and functional capillaries.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Regenerative medication and stemcells are regularly expressed inside a similar breath, in light ofcurrent circumstances. There is a basic need to recognize stem cells that canframe spontaneously beating cardiomyocytes (CMs) and empower regeneration.Utilization of Cdx2 cells may play a vital development, as these stem cells aremultipotent and immunologically naive, with a remarkable proteome, contrastedand embryonic stemcells. Additionally, they show the capacity to specifically home tosites of injury. These qualities prepare for novel allogeneic stem celltreatment for cardiovascular infection. Specialists have figured out how toutilize placental stemcells to recover heart cells in mice, which could prompt momentousnew medications for heartattack patients.

Related Conferences: 4th AnnualAdvances in PulmonaryHypertension, Aug 02, 2019, Chicago, USA | HeartTeam Summit, October 18-19, 2019, Chicago, USA | 2nd World Heart Rhythm Conference,November 25-26, 2019, Dubai, UAE | 34th World CardiologyConference, Dec 02-03, 2019, Dubai, UAE

Call for Abstracts

Scientific Program

Submit Abstract

Previous Conferences

Allied Academies Global Conference Directory

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Conferences by Subject

Medical & Clinical Conferences

Non Medical Conferences

Call for Abstracts

Scientific Program

Session on: Cardiology

Session on: Cardiac Diseases

Session on: Heart Failure

Session on: Atrial Fibrillation and Arrhythmias

Session on: Congenital Heart Disease and Paediatric Cardiology

Session on: Interventional Cardiology and Cardiovascular Surgery

Session on: Diabetes and Heart Disease

Session on: Thyroid Disease and the Heart

Session on: Cardiac Imaging

Session on: Cardiovascular Nursing and Healthcare

Session on: Women & Heart Disease

Session on: Digital Health and Cardiology

Session on: Cardiovascular Pharmacology

Session on: Stem cell and Regenerative Biology

Submit Abstract

Previous Conferences

Allied Academies Global Conference Directory

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Conferences by Subject

Medical & Clinical Conferences

Non Medical Conferences